Vicarious Surgical Inc (NYSE:RBOT) Short Interest Down 21.2% in May

Vicarious Surgical Inc (NYSE:RBOTGet Free Report) was the target of a large decrease in short interest during the month of May. As of May 15th, there was short interest totalling 5,210,000 shares, a decrease of 21.2% from the April 30th total of 6,610,000 shares. Based on an average trading volume of 596,300 shares, the days-to-cover ratio is presently 8.7 days.

Vicarious Surgical Stock Up 5.9 %

Shares of RBOT traded up $0.02 during trading hours on Friday, hitting $0.32. The company had a trading volume of 320,152 shares, compared to its average volume of 404,677. Vicarious Surgical has a 52-week low of $0.20 and a 52-week high of $2.37. The stock’s 50 day moving average price is $0.31 and its 200 day moving average price is $0.36.

Vicarious Surgical (NYSE:RBOTGet Free Report) last announced its quarterly earnings data on Monday, April 29th. The company reported ($0.09) earnings per share for the quarter, beating the consensus estimate of ($0.10) by $0.01. On average, equities analysts expect that Vicarious Surgical will post -0.36 EPS for the current year.

Hedge Funds Weigh In On Vicarious Surgical

A number of hedge funds have recently modified their holdings of the company. SRS Capital Advisors Inc. increased its position in Vicarious Surgical by 215.0% during the 4th quarter. SRS Capital Advisors Inc. now owns 87,905 shares of the company’s stock valued at $32,000 after purchasing an additional 60,000 shares during the period. Hudson Bay Capital Management LP bought a new position in shares of Vicarious Surgical in the 3rd quarter worth approximately $207,000. Seven Grand Managers LLC purchased a new position in shares of Vicarious Surgical in the 3rd quarter valued at approximately $295,000. Regal Partners Ltd bought a new stake in shares of Vicarious Surgical during the third quarter valued at approximately $390,000. Finally, Element Capital Management LLC purchased a new stake in Vicarious Surgical in the third quarter worth $585,000. Hedge funds and other institutional investors own 47.27% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Piper Sandler reduced their price objective on Vicarious Surgical from $1.50 to $1.00 and set a “neutral” rating on the stock in a research report on Tuesday, March 5th.

Get Our Latest Analysis on RBOT

Vicarious Surgical Company Profile

(Get Free Report)

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Recommended Stories

Receive News & Ratings for Vicarious Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicarious Surgical and related companies with's FREE daily email newsletter.